CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Emtricitabine

恩曲他滨 杂质对照品Emtricitabine Impurities

46 个杂质条目46 impurity entries

本页汇总 恩曲他滨 的 46 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Emtricitabine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 恩曲他滨(Emtricitabine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesUPLC-PDA Approach for Simultaneous Quantification of Elvitegravir, Tenofovir, Emtricitabine and Cobicistat in Tablets: An MS-ESI Study for Degradation Products
    Journal of chromatographic science · 2024 · Nimmagadda RL, Gummadi S  ·  PMID 37691589  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance
    Journal of separation science · 2007 · Seshachalam U et al.  ·  PMID 17566333  ·  DOI
  3. 杂质研究Impurity studiesStability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms
    International scholarly research notices · 2014 · Venkatesan S et al.  ·  PMID 27437485  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of (±)-Emtricitabine and (±)-Lamivudine by Chlorotrimethylsilane-Sodium Iodide-Promoted Vorbrüggen Glycosylation
    The Journal of organic chemistry · 2022 · Mear SJ et al.  ·  PMID 35030006  ·  DOI
  • 合成方法SynthesisA Continuous Flow Sulfuryl Chloride-Based Reaction-Synthesis of a Key Intermediate in a New Route toward Emtricitabine and Lamivudine
    Organic process research & development · 2020 · de Souza JM et al.  ·  PMID 33100813  ·  DOI

恩曲他滨 —— 原料药与杂质对照品Emtricitabine — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Emtricitabine structure
原料药 APIAPI
恩曲他滨Emtricitabine
Emtricitabine
CAS No.143491-57-0
Chemical FormulaC8H10FN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
1-Terpinen-4-Ol structure
—
4-萜烯醇1-Terpinen-4-Ol
1-Terpinen-4-Ol
CAS No.562-74-3
Chemical FormulaC10H18O
Purity>95%现货In stock
10mg25mg50mg100mg
Emtricitabine Impurity 1 structure
1
恩曲他滨杂质1Emtricitabine Impurity 1
Emtricitabine Impurity 1
CAS No.145986-11-4
Chemical FormulaC8H9FN2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 2 structure
2
恩曲他滨杂质2Emtricitabine Impurity 2
Emtricitabine Impurity 2
CAS No.152128-77-3
Chemical FormulaC8H10FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 3 structure
3
恩曲他滨杂质3Emtricitabine Impurity 3
Emtricitabine Impurity 3
CAS No.1238210-10-0
Chemical FormulaC8H8FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 4 (Mixture of E/Z-isomers) structure
4
恩曲他滨杂质4 (混合 E/Z 构型)Emtricitabine Impurity 4 (Mixture of E/Z-isomers)
Emtricitabine Impurity 4 (Mixture of E/Z-isomers)
CAS No.860-22-0
Chemical FormulaC16H8N2O8S22-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 5 structure
5
恩曲他滨杂质5Emtricitabine Impurity 5
Emtricitabine Impurity 5
CAS No.147126-63-4
Chemical FormulaC14H24O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 6 structure
6
恩曲他滨杂质6Emtricitabine Impurity 6
Emtricitabine Impurity 6
CAS No.147126-64-5
Chemical FormulaC14H24O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 7 structure
7
恩曲他滨杂质7Emtricitabine Impurity 7
Emtricitabine Impurity 7
CAS No.147027-08-5
Chemical FormulaC14H24O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 8 structure
8
恩曲他滨杂质8Emtricitabine Impurity 8
Emtricitabine Impurity 8
CAS No.145397-26-8
Chemical FormulaC8H10FN3O4
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 13 structure
13
恩曲他滨杂质13Emtricitabine Impurity 13
Emtricitabine Impurity 13
CAS No.143491-58-1
Chemical FormulaC12H16FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 14 (Emtricitabine Disulfide) structure
14
恩曲他滨杂质14 (恩曲他滨二硫化物)Emtricitabine Impurity 14 (Emtricitabine Disulfide)
Emtricitabine Impurity 14 (Emtricitabine Disulfide)
CAS No.2331211-44-8
Chemical FormulaC16H18F2N6O4S4
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 15 structure
15
恩曲他滨杂质15Emtricitabine Impurity 15
Emtricitabine Impurity 15
CAS No.1238210-22-4
Chemical FormulaC8H9FN2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 17 structure
17
恩曲他滨杂质17Emtricitabine Impurity 17
Emtricitabine Impurity 17
CAS No.1238210-14-4
Chemical FormulaC8H11N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 18 structure
18
恩曲他滨杂质18Emtricitabine Impurity 18
Emtricitabine Impurity 18
CAS No.137530-41-7
Chemical FormulaC8H10FN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 19 structure
19
恩曲他滨杂质19Emtricitabine Impurity 19
Emtricitabine Impurity 19
CAS No.145416-34-8
Chemical FormulaC8H10FN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 20 structure
20
恩曲他滨杂质20Emtricitabine Impurity 20
Emtricitabine Impurity 20
CAS No.145986-26-1
Chemical FormulaC8H10FN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 21 structure
21
恩曲他滨杂质21Emtricitabine Impurity 21
Emtricitabine Impurity 21
CAS No.1422361-25-8
Chemical FormulaC18H25FN2O5S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 22 structure
22
恩曲他滨杂质22Emtricitabine Impurity 22
Emtricitabine Impurity 22
CAS No.147027-01-8
Chemical FormulaC18H26FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 23 structure
23
恩曲他滨杂质23Emtricitabine Impurity 23
Emtricitabine Impurity 23
CAS No.147126-75-8
Chemical FormulaC18H26FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 25 structure
25
恩曲他滨杂质25Emtricitabine Impurity 25
Emtricitabine Impurity 25
CAS No.1773498-61-5
Chemical FormulaC18H26FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 26 structure
26
恩曲他滨杂质26Emtricitabine Impurity 26
Emtricitabine Impurity 26
CAS No.61548-81-0
Chemical FormulaC11H22O3S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 28(Emtricitabine and Tenofovir Disoproxil Fumarate Impurity 2) structure
28
恩曲他滨杂质28(恩曲他滨和富马酸替诺福韦酯杂质2)Emtricitabine Impurity 28(Emtricitabine and Tenofovir Disoproxil Fumarate Impurity 2)
Emtricitabine Impurity 28(Emtricitabine and Tenofovir Disoproxil Fumarate Impurity 2)
CAS No.1962114-95-9
Chemical FormulaC17H22FN8O6PS
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 32 structure
32
恩曲他滨杂质32Emtricitabine Impurity 32
Emtricitabine Impurity 32
CAS No.145032-08-2
Chemical FormulaC10H12FN3O4S
Purity>95%现货In stock
10mg25mg50mg100mg
Emtricitabine Impurity 34 structure
34
恩曲他滨杂质34Emtricitabine Impurity 34
Emtricitabine Impurity 34
CAS No.89124-16-3
Chemical FormulaC4H6Cl2S2
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 35 structure
35
恩曲他滨杂质35Emtricitabine Impurity 35
Emtricitabine Impurity 35
CAS No.16052-42-9
Chemical FormulaC10H19Cl
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 36 structure
36
恩曲他滨杂质36Emtricitabine Impurity 36
Emtricitabine Impurity 36
CAS No.288325-76-8
Chemical FormulaC14H23ClO3S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 37 structure
37
恩曲他滨杂质37Emtricitabine Impurity 37
Emtricitabine Impurity 37
CAS No.200396-21-0
Chemical FormulaC18H27N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 39 structure
39
恩曲他滨杂质39Emtricitabine Impurity 39
Emtricitabine Impurity 39
CAS No.1160303-44-5
Chemical FormulaC8H10FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 40 structure
40
恩曲他滨杂质40Emtricitabine Impurity 40
Emtricitabine Impurity 40
CAS No.20747-49-3
Chemical FormulaC10H20O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 41 structure
41
恩曲他滨杂质41Emtricitabine Impurity 41
Emtricitabine Impurity 41
CAS No.64282-88-8
Chemical FormulaC10H20O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 42 structure
42
恩曲他滨杂质42Emtricitabine Impurity 42
Emtricitabine Impurity 42
CAS No.2216-52-6
Chemical FormulaC10H20O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 43 structure
43
恩曲他滨杂质43Emtricitabine Impurity 43
Emtricitabine Impurity 43
CAS No.23283-97-8
Chemical FormulaC10H20O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 44 structure
44
恩曲他滨杂质44Emtricitabine Impurity 44
Emtricitabine Impurity 44
CAS No.7786-67-6
Chemical FormulaC10H18O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 46 structure
46
恩曲他滨杂质46Emtricitabine Impurity 46
Emtricitabine Impurity 46
CAS No.1962114-91-1
Chemical FormulaC17H20F2N6O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 52 structure
52
恩曲他滨杂质52Emtricitabine Impurity 52
Emtricitabine Impurity 52
CAS No.18675-33-7
Chemical FormulaC10H18O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 53 structure
53
恩曲他滨杂质53Emtricitabine Impurity 53
Emtricitabine Impurity 53
CAS No.143790-05-0
Chemical FormulaC8H9FN2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 54 structure
54
恩曲他滨杂质54Emtricitabine Impurity 54
Emtricitabine Impurity 54
CAS No.2101981-64-8
Chemical FormulaC8H10FN3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 56 (Mixture of Enantiomers) structure
56
恩曲他滨杂质56 (对映异构体混合物)Emtricitabine Impurity 56 (Mixture of Enantiomers)
Emtricitabine Impurity 56 (Mixture of Enantiomers)
CAS No.3623-52-7
Chemical FormulaC10H20O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 57 structure
57
恩曲他滨杂质57Emtricitabine Impurity 57
Emtricitabine Impurity 57
CAS No.145281-92-1
Chemical FormulaC8H9FN2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 59 structure
59
恩曲他滨杂质59Emtricitabine Impurity 59
Emtricitabine Impurity 59
CAS No.89-79-2
Chemical FormulaC10H18O
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 60 structure
60
恩曲他滨杂质60Emtricitabine Impurity 60
Emtricitabine Impurity 60
CAS No.2724503-31-3
Chemical FormulaC8H9FN2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 61 structure
61
恩曲他滨杂质61Emtricitabine Impurity 61
Emtricitabine Impurity 61
CAS No.152128-78-4
Chemical FormulaC14H18FN3O9S
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 63 structure
63
恩曲他滨杂质63Emtricitabine Impurity 63
Emtricitabine Impurity 63
CAS No.13405-87-3
Chemical FormulaC4H6Cl2S2
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 64 structure
64
恩曲他滨杂质64Emtricitabine Impurity 64
Emtricitabine Impurity 64
CAS No.6087-13-4
Chemical FormulaC3H5FO2
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 65 structure
65
恩曲他滨杂质65Emtricitabine Impurity 65
Emtricitabine Impurity 65
CAS No.145397-25-7
Chemical FormulaC8H10FN3O4
Purity>95%询价On request
10mg25mg50mg100mg
Emtricitabine Impurity 69 structure
69
恩曲他滨杂质69Emtricitabine Impurity 69
Emtricitabine Impurity 69
CAS No.1246819-86-2
Chemical FormulaC9H12FN3O2S2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

恩曲他滨 —— 研究文献与合成路线Emtricitabine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 恩曲他滨 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Emtricitabine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability behavior of antiretroviral drugs and their combinations. 7: Comparative degradation pathways of lamivudine and emtricitabine and explanation to their differential degradation behavior by density functional theory
    Kurmi M, Singh S · Journal of pharmaceutical and biomedical analysis · 2017 · 被引 11cited 11
  2. A Validated Stability Indicating RP-HPLC Method for the Determination of Emtricitabine, Tenofovir Disoproxil Fumarate, Elvitegravir and Cobicistat in Pharmaceutical Dosage Form
    Runja C, Kumar PR, Avanapu SR · Journal of chromatographic science · 2016 · 被引 11cited 11
  3. Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance
    Seshachalam U, Haribabu B, Chandrasekhar KB · Journal of separation science · 2007 · 被引 9cited 9
  4. HPLC method for the determination of emtricitabine and related degradation substances
    Hamarapurkar PD, Parate AN · Journal of chromatographic science · 2013 · 被引 5cited 5
  5. UPLC-PDA Approach for Simultaneous Quantification of Elvitegravir, Tenofovir, Emtricitabine and Cobicistat in Tablets: An MS-ESI Study for Degradation Products
    Nimmagadda RL, Gummadi S · Journal of chromatographic science · 2024 · 被引 1cited 1
  6. Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in emtricitabine active pharmaceutical ingredient by LC/MS/MS using electrospray ionization
    Kakadiya PR, Chandrashekhar TG, Ganguly S, et al. · Analytical chemistry insights · 2011 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR OBTAINING EMTRICITABINE
    BARTRA SANMARTI MARTI, BERENGUER MAIMO RAMON, SOLSONA ROCABERT JOAN GABRIEL · 公开号 WO2011120927WO2011120927 · 2011
  2. Process for obtaining emtricitabine
    BARTRA SANMARTI MARTI, BERENGUER MAIMO RAMON, SOLSONA ROCABERT JOAN GABRIEL · 公开号 EP2377862EP2377862 · 2011
  3. A NOVEL POLYMORPH OF EMTRICITABINE AND A PROCESS FOR PREPARING OF THE SAME
    SINGH GIRIJ PAL, SRIVASTAVA DHANANJAI, JADHAV HARISHCHANDRA, PATHAK SHAILENDRA, et al. · 公开号 WO2010055526WO2010055526 · 2010
  4. NOVEL POLYMORPH OF EMTRICITABINE AND A PROCESS FOR PREPARING OF THE SAME
    SINGH GIRIJ PAL, SRIVASTAVA DHANANJAI, JADHAV HARISHCHANDRA, PATHAK SHAILENDRA, et al. · 公开号 US2011288298US2011288298 · 2011
  5. A NOVEL POLYMORPH OF EMTRICITABINE AND A PROCESS FOR PREPARING OF THE SAME
    SINGH GIRIJ PAL, SRIVASTAVA DHANANJAI, JADHAV HARISHCHANDRA, PATHAK SHAILENDRA, et al. · 公开号 EP2350065EP2350065 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

恩曲他滨 杂质谱研究要点Emtricitabine — impurity profiling notes

下面这些是拿到 恩曲他滨 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Emtricitabine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances